ClinicalTrials.gg
RecruitingNCT03979235Updated Nov 13, 2026

Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation

An observational study in Healthy Volunteers, Motor Deficits and Dysphagia, sponsored by National Research Center for Rehabilitation Technical Aids. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by National Research Center for Rehabilitation Technical Aids · Observational

How we know

From the registry’s dates

  • Started Jun 2019; still recruiting 7 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Neurologic Manifestations with a site in China — 11 open to participants now, 11 under way, none of them phase 3. Neurologic Manifestations · China.

Planned enrollment
9th of 10
40 · median 231
Started
2019
the only one that year
Observational
10 of 24
5 open now
Primary completion
2026-12
later than 7 of 10 live
Registered
8th of 24
by date
Lead sponsor
1 of 24
National Research Center for Rehabilitation Technical Aids

Among the 24 studies in Neurologic Manifestations with a site in China, this one is the 9th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2019, is one of 10 observational ones, reaches primary completion later than 7 of the 10 other live ones, and was the 8th registered.

Neurologic Manifestations

427 studies on the registry are indexed under Neurologic Manifestations; 80 are open to participants now.

Browse Neurologic Manifestations studies →

Open to participants now

11 of the 24 studies in Neurologic Manifestations with a site in China are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 59 Neurologic Manifestations studies recruiting now, 31 (53%) set no upper age limit and 15 (25%) stop at 75 or younger; 15 take children under 18; 12 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Neurologic Manifestations with a site in China, or all of them as a file.
02

Study summary

Using robotics, sensors, and sEMG to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Read the detailed description

Using robotics, sensors, sEMG or other methods to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

03

Conditions studied

  • Healthy Volunteers
  • Motor Deficits
  • Dysphagia
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Recruiting with advertising

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • no history of psychological/psychotic problems, no history of important diseases.

Exclusion criteria

Exclusion Criteria (for healthy people):

  • history of psychological/psychotic problems

Inclusion Criteria (for patients with motor deficits or dysphagia):

  • patients with motor function impairment such as post stroke hemiplegia.

Exclusion Criteria (for patients with motor deficits or dysphagia):

  • cognitively or physically unable to cooperate with the examiner to finish the test
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Heahlthy people

    perform motor function assessment by using scales, sEMG, and inertia sensors

    Diagnostic Test: Motor function assessment

  • People with motor deficits

    perform motor function assessment by using scales, sEMG, and inertia sensors

    Diagnostic Test: Motor function assessment

  • Patients with dysphagia

    perform motor function assessment by using scales, sEMG, and inertia sensors

    Diagnostic Test: Motor function assessment

Interventions

  • Diagnostic testMotor function assessment

    perform motor function assessment by using scales, sEMG, and inertia sensors

06

What researchers measure

Primary outcomes

  1. Motor function assessment

    Fugl-Meyer Assessment

    Time frame: Change from Baseline scores at 1 month

Secondary outcomes

  1. surface EMG

    high-density surface EMG

    Time frame: Change from Baseline status at 1 month

  2. Kinematics test

    Using inertia sensors to assess kinematics during movement

    Time frame: Change from Baseline status at 1 month

07

Study locations

1 of 1 sites recruiting
  • National Research Center for Rehabilitation Technical Aids
    Beijing, 100176, China
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2019 (actual). Primary completion is estimated for Dec 2026, 90 months after the start.

Of 52 non-industry observational studies under Neurologic Manifestations, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 339. This study's planned 90 months is above that.

Counting every sponsor, half of 59 studies reached it within 39 months; a quarter within 22 and three quarters within 339.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2019
First posted
Jun 7, 2019
StartActual
Jun 5, 2019
Primary completionEst.
Dec 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT03979235
Lead sponsor
National Research Center for Rehabilitation Technical Aids
Responsible party
Pengxu Wei (Director, National Research Center for Rehabilitation Technical Aids) — Principal investigator
First posted
Jun 7, 2019
Start date
Jun 5, 2019
Primary completion
Dec 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 13, 2026

Study contacts

LT Wang, PhD
Contact
suhonglun@nrcrta.cn
86-10-58122882
PX Wei, PhD
Contact
pengxuwei@gmail.com
86-10-58122921
PX Wei, PhD
principal investigator · National Research Center for Rehabilitation Technical Aids

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion